The role of mass spectrometry in vaccine development

Vaccine

Volumn 19, Issue 17-19, 2001, Pages 2692-2700

  Poland, Gregory A ^a   Ovsyannikova, Inna G ^a   Johnson, Kenneth L ^b   Naylor, Stephen ^b  

^a Mayo Vaccine Research Group   (United States)

^b MAYO CLINIC   (United States)

Author keywords

HLA; Mass spectrometry; Vaccine development

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; VACCINE;

ACCURACY; AMINO ACID SEQUENCE; ANALYTIC METHOD; ANTIGEN BINDING; CONFERENCE PAPER; DATA BASE; DRUG DESIGN; HAPLOTYPE; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION; MASS SPECTROMETRY; MOLECULE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DATABASES, FACTUAL; EPITOPES; HLA ANTIGENS; HUMANS; MASS SPECTROMETRY; PEPTIDES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; T-LYMPHOCYTES; VACCINES;

EID: 0035925564     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00505-3     Document Type: Conference Paper

References (63)

1. Peptide epitope mapping in vaccine development: Introduction
2. Safety of vaccines
3. Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus
4. Synthetic peptide vaccines: Success at last
5. Vaccine developments
6. The biology of the immune system
7. Structural basis of T cell recognition
8. A biological role for the major histocompatibility antigens
9. Structure of peptides associated with class I and class II MHC molecules
10. Antigen presentation in the immune response to infectious diseases
11. Use of synthetic peptides to identify measles nucleoprotein T-cell epitopes in vaccinated and naturally infected humans
12. Characterization of T cell epitopes in measles virus nucleoprotein
13. The adjuvant effect of a non-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide
14. Human leukocyte antigen class I- and class II-restricted cytotoxic T lymphocyte responses to measles antigens in immune adults
15. HLA allele selection for designing peptide vaccines
16. Description and prediction of peptide-MHC binding: The 'human MHC project'
17. Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice
18. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning
19. Several common HLA-DR types share largely overlapping peptide binding repertoires
20. Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules
21. Isolation and rapid identification of an abundant self-peptide from class II HLA-DRB1*0401 alleles induced by measles vaccine virus infection
22. A single naturally processed measles virus peptide fully dominates the HLA-A*0201-associated peptide display and is mutated at its anchor position in persistent viral strains
23. HLA-DR promiscuous T cell epitopes from Plasmodium falciparum ore-erythrocytic-state antigens restricted by multiple HLA class II alleles
24. Reverse immunogenetics: From HLA-disease associations to vaccine candidates
25. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry
26. A microcapillary column switching HPLC-electrospray ionization MS system for the direct identification of peptides presented by major histocompatibility complex class I molecules
27. Perfusion chromatography for very rapid purification of class I and II MHC proteins
28. Sheathless preconcentration-capillary zone electrophoresis-mass spectrometry applied to peptide analysis
29. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size
30. Analysis of naturally processed peptides eluted from HLA DRB1*0402 and *0404
31. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad
32. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database
33. Mass spectrometry for genotyping: An emerging tool for molecular medicine
34. Electrospray ionization for mass spectrometry of large biomolecules
35. A brief overview of the present status of the mechanisms involved in electrospray mass spectrometry
36. On the mechanism of electrospray mass spectrometry
37. Future prospects for the analysis of complex biological systems using micro-column liquid chromatography-electrospray tandem mass spectrometry
38. Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules
39. The minimal number of class II MHC-antigen complexes needed for T cell activation
40. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation
41. HLA-A2.1-associated peptides from a mutant cell line: A second pathway of antigen presentation
42. Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant
43. Strategy for isolating and sequencing biologically derived MHC class I peptides
44. Rapid loading of large sample volumes, analyte cleanup, and modified moving boundary transient isotachophoresis conditions for membrane preconcentration-capillary electrophoresis in small diameter capillaries
45. Utility of membrane preconcentration-capillary electrophoresis-mass spectrometry in overcoming limited sample loading for analysis of biological derived drug metabolites, peptides, and proteins
46. Identification of a naturally occurring ligand for thymic positive selection
47. Strategy for isolation of measles vaccine virus (MVV) processed peptides from class II HLA-DR4 alleles
48. Use of a HLA-DR4 homozygous human B-cell line and mass spectrometry as a model to study measles peptide processing and presentation
49. Membrane preconcentration CE
50. Membrane preconcentration-capillary chromatography-MS
51. Mining genomes: Correlating tandem mass spectra of modified and unmodified peptides to sequences in nucleotide databases
52. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database
53. Hunting for genes in computer data bases
54. Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope
55. Sequence analysis of major histocompatibility
56. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides